The Latest Cardiac and Vascular News
February 29, 2024 New CT 5300 system provides more accurate and reliable imaging results to better manage increase in complex cardiac cases where precise patient diagnosis is crucial Philips’ latest innovation leverages the power of AI at every stage in CT scanner operation to enhance productivity and diagnostic capabilities of […]
Regulatory approval for the first fully integrated PFA system with a CARTO-enabled simple and reproducible workflow. Integrated with the world’s leading CARTO™ 3D Cardiac Mapping System for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AF). CE Mark…
Q4 2023 reported revenue of $324.5 million, up 10.6% year-over-year Q4 2023 constant currency revenue* up 10.3% year-over-year Q4 2023 constant currency revenue, organic* up 8.3% year-over-year Q4 2023 GAAP operating margin of 10.4%, compared to 10.4% in Q4 2022 Q4 2023 non-GAAP operating margin* of 18.2%, compared to 17.8% […]
Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Guided Therapy Mobile C-arm System 9000 – Zenition 90 Motorized, designed to help surgeons deliver high-quality care to more patients. The new mobile C-arm with expanded capabilities […]
Proprietary AI companion technology assists electrophysiologists by reducing ambiguity in mapped atrial fibrillation (AF) patterns MARSEILLE, France, Feb. 28, 2024 (GLOBE NEWSWIRE) — Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists, today announced CE (Conformité Européenne) Mark according to the new European Medical […]
American Heart Association consortium advances development of evidence-based health tech solutions SOFIA, Bulgaria, Feb. 28, 2024 /PRNewswire/ — Kelvin Health, diagnostic solution aiming to advance the standard of vascular care by applying modern AI to mobile thermography imaging, has…
BURLINGTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) — LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2023 results, announced a $0.16/share quarterly dividend and provided guidance. Q4 2023 Financial Results Sales $48.9mm, +19% (+14% organic) vs. Q4 2022 Gross margin 68.1%, +450 bps Op. income […]
Irvine, CA – February 27, 2024 – Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech[i], announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax® Inc., a pioneer in the development of innovative, polymer heart valves, today announced a manufacturing agreement with Dolphin Life Science India LLP to enable in-country manufacturing of the TRIA™ polymer mitral surgical heart valve outside of the U.S. for the first time. “We are honored to collaborate […]
